Change of Adviser

25th Jun 2009 13:00



25 June 2009

e-Therapeutics plc

Change of Adviser

The Board of e-Therapeutics plc (the 'Company') (AIM: ETX), the drug discovery and development company, is pleased to announce the appointment of Canaccord Adams Limited as the Nominated Adviser and Broker to the Company with immediate effect.

Enquiries:

e-Therapeutics plc  O191 233 1317

John Cordiner, Finance Director

Canaccord Adams Limited

Nominated Adviser 0207 050 6500

Robert Finlay / Henry Fitzgerald-O'Connor

ENDAPPBELFLKQBEBBK

---

Related Shares:

ETX.L